NCT06861452
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06861452
Title Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients with Locally Advanced Pancreatic Carcinoma (SNIPER)
Acronym SNIPER
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EIR Biotherapies s.r.l.
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.